Cargando…

Predicting Cognitive Decline in Older Adults Using Baseline Metrics of AD Pathologies, Cerebrovascular Disease, and Neurodegeneration

BACKGROUND AND OBJECTIVES: Dementia is a growing socioeconomic challenge that requires early intervention. Identifying biomarkers that reliably predict clinical progression early in the disease process would better aid selection of individuals for future trial participation. Here, we compared the ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prosser, Lloyd, Macdougall, Amy, Sudre, Carole H., Manning, Emily N., Malone, Ian B., Walsh, Phoebe, Goodkin, Olivia, Pemberton, Hugh, Barkhof, Frederik, Biessels, Geert Jan, Cash, David M., Barnes, Josephine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984210/ https://www.ncbi.nlm.nih.gov/pubmed/36357185 http://dx.doi.org/10.1212/WNL.0000000000201572

Ejemplares similares

Presumed small vessel disease, imaging and cognition markers in the Alzheimer’s Disease Neuroimaging Initiative
por: Fiford, Cassidy M, et al.
Publicado: (2021)

Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change
por: Fiford, Cassidy M., et al.
Publicado: (2020)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017)

Alzheimer’s disease, cerebrovascular disease and dementia: lump, split or integrate?
por: Biessels, Geert Jan
Publicado: (2022)

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2018)

White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy
por: Fiford, Cassidy M., et al.
Publicado: (2017)

Vascular Effects on Cerebrovascular Permeability and Neurodegeneration
por: Sulimai, Nurul, et al.
Publicado: (2023)

Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence
por: Mendelsohn, Zoe, et al.
Publicado: (2022)

FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis
por: Goodkin, O., et al.
Publicado: (2020)

Preliminary validation of a structural magnetic resonance imaging metric for tracking dementia-related neurodegeneration and future decline
por: Kress, Gavin T., et al.
Publicado: (2023)

Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review
por: Pemberton, Hugh G., et al.
Publicado: (2021)

STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individuals
por: Harding, Ian H, et al.
Publicado: (2023)

Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline
por: Ebenau, Jarith L., et al.
Publicado: (2022)

DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease
por: Sala-Vila, Aleix, et al.
Publicado: (2021)

Patterns of progressive atrophy vary with age in Alzheimer's disease patients
por: Fiford, Cassidy M., et al.
Publicado: (2018)

Aggregation of Disordered Proteins Associated with Neurodegeneration
por: Tsoi, Phoebe S., et al.
Publicado: (2023)

Cortical involvement determines impairment 30 years after a clinically isolated syndrome
por: Haider, Lukas, et al.
Publicado: (2021)

Completeness of the circle of Willis and risk of ischemic stroke in patients without cerebrovascular disease
por: van Seeters, Tom, et al.
Publicado: (2015)

Vascular Cognitive Impairment and cognitive decline; a longitudinal study comparing different types of vascular brain injury - The TRACE-VCI study
por: Boomsma, Jooske MF, et al.
Publicado: (2022)

Hippocampal profiling: Localized magnetic resonance imaging volumetry and T2 relaxometry for hippocampal sclerosis
por: Vos, Sjoerd B., et al.
Publicado: (2019)

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results
por: Aalten, Pauline, et al.
Publicado: (2014)

Causes, effects and connectivity changes in MS-related cognitive decline
por: Rimkus, Carolina de Medeiros, et al.
Publicado: (2016)

Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort
por: Buchanan, Sarah M., et al.
Publicado: (2020)

Improving Cerebrovascular Function to Increase Neuronal Recovery in Neurodegeneration Associated to Cardiovascular Disease
por: Vanherle, Lotte, et al.
Publicado: (2020)

Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease
por: Almeria, Marta, et al.
Publicado: (2023)

Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain
por: Dintica, Christina S., et al.
Publicado: (2019)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

Comparison of Diffusion Tensor Imaging Metrics in Normal-Appearing White Matter to Cerebrovascular Lesions and Correlation with Cerebrovascular Disease Risk Factors and Severity
por: Haddad, Seyyed M. H., et al.
Publicado: (2022)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
por: Lao, Patrick J., et al.
Publicado: (2018)

Baseline metrics that may predict future myopia in young children
por: Vera-Diaz, Fuensanta A., et al.
Publicado: (2023)

Multimodal tract-based MRI metrics outperform whole brain markers in determining cognitive impact of small vessel disease-related brain injury
por: De Luca, Alberto, et al.
Publicado: (2022)

Associations of β-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort
por: Keuss, Sarah E., et al.
Publicado: (2022)

Determining the Role of ApoE4 in Age-Related Cerebrovascular Decline
por: Foley, Kate, et al.
Publicado: (2020)

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
por: Wang, Qing, et al.
Publicado: (2022)

Noradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia
por: Leanza, Giampiero, et al.
Publicado: (2018)

CHIP Decline Is Associated With Isoflurane-Induced Neurodegeneration in Aged Mice
por: Xu, Qiaoqiao, et al.
Publicado: (2022)

Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice
por: Tóth, Melinda E., et al.
Publicado: (2020)

Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women
por: Wong, Rachel H.X., et al.
Publicado: (2016)

Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19
por: Schwarz, Viktoria, et al.
Publicado: (2020)

Relationship Between Cerebrovascular Reactivity and Cognition Among People With Risk of Cognitive Decline
por: Kim, Donghoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_727q722iqop4lu1j9s3dtdpkag